UBS Group’s Simplify VettaFi Private Credit Strategy ETF PCR Stock Holding History

UBS Group’s Portfolio PCR Stock Details PCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176	Buy	+9	New	+$181	﹤0.01%	10026

Other funds holding PCR

BIG

Brookwood Investment Group Phoenix, Arizona $888M AUM 32.21% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

RIA

Realta Investment Advisors Wilmington, Delaware $322M AUM 39.45% 1-Year Est. Return

UBS Group's PCR Position: Q2 2026 in Review

UBS Group opened a new position in Simplify VettaFi Private Credit Strategy ETF (PCR) in Q2 2026: 9 shares worth $176. The stake represents ﹤0.01% of the portfolio and ranks #10026 among its holdings.

4 funds tracked by Wall St. Rank hold PCR as of Q2 2026.

UBS Group held 9 shares of Simplify VettaFi Private Credit Strategy ETF worth $176 as of Q2 2026.
Simplify VettaFi Private Credit Strategy ETF was a new UBS Group position in Q2 2026.
Simplify VettaFi Private Credit Strategy ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10026 holding.
4 funds tracked by Wall St. Rank held Simplify VettaFi Private Credit Strategy ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.